Focusing on Clinical and Research Services

Director of Corporate Development

Smooth Drug Development

Aug 9, 2017PTV-M06-17-BIO-006

Julia Sardayan, Director of Corporate Development, Smooth Drug Development

Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.

Reach Our Team

Subscribe for the newsletter

Subscribe for the Newsletter

Mobile Navigation

Focusing on Clinical and Research Services

Related Content

Pathfinder

Basket vs. Umbrella Clinical Trials: Which Precision Oncology Trial Design Is Better?

Pharma's Almanac

Pathfinder

Adaptive Trials vs. Traditional Randomized Controlled Trials: Which Clinical Trial Design Is Better?

Pharma's Almanac

Basket Trials

Basket Trials and the Future of Rare Cancer Research

David Alvaro, Ph.D.

Pharma's Almanac

Pathfinder

Site-Based vs. Decentralized vs. Hybrid Clinical Trials: Which Model Is Best for Modern Clinical Research?

Pharma's Almanac

Adaptive Trials

Designing for Change: Adaptive Clinical Trials and the Evolving Path to Regulatory Acceptance

Pharma's Almanac

CNS Clinical

Insilico Completes First-in-Human Dosing in Phase I Clinical Study of AI-Driven NLRP3 Inhibitor ISM8969

Insilico Medicine

Expedited Pathways

Accelerated Pathways: Are They Delivering on Their Promise?

David Alvaro, Ph.D.

Pharma's Almanac

Clinical Evidence

Rethinking Clinical Evidence Requirements in Rare Diseases

David Alvaro, Ph.D.

Pharma's Almanac

Clinical Trial Needs

Bridging the Gap: Addressing Unmet Needs in Cardiology, Neuroscience, and Respiratory Trials

Bethany Davis, M.D.

Trialmed

Neuro Biomarkers

Precision Neurology: How Biomarkers Are Redefining Clinical Trial Design

David Alvaro, Ph.D.

Pharma's Almanac

Clinical Partnership

Quotient Sciences and Biorasi Partner to Accelerate Early Phase Clinical Trials to Patient Proof-of-Concept

Quotient Sciences

Drug Development

Lindus Health and Quotient Sciences Partner to Accelerate Drug Development from First-in-Human to Pivotal Trials

Quotient Sciences

Related Content

Pathfinder

Basket vs. Umbrella Clinical Trials: Which Precision Oncology Trial Design Is Better?

Pharma's Almanac

Pathfinder

Adaptive Trials vs. Traditional Randomized Controlled Trials: Which Clinical Trial Design Is Better?

Pharma's Almanac

Basket Trials

Basket Trials and the Future of Rare Cancer Research

David Alvaro, Ph.D.

Pharma's Almanac

Pathfinder

Site-Based vs. Decentralized vs. Hybrid Clinical Trials: Which Model Is Best for Modern Clinical Research?

Pharma's Almanac

Adaptive Trials

Designing for Change: Adaptive Clinical Trials and the Evolving Path to Regulatory Acceptance

Pharma's Almanac

CNS Clinical

Insilico Completes First-in-Human Dosing in Phase I Clinical Study of AI-Driven NLRP3 Inhibitor ISM8969

Insilico Medicine

Expedited Pathways

Accelerated Pathways: Are They Delivering on Their Promise?

David Alvaro, Ph.D.

Pharma's Almanac

Clinical Evidence

Rethinking Clinical Evidence Requirements in Rare Diseases

David Alvaro, Ph.D.

Pharma's Almanac

Clinical Trial Needs

Bridging the Gap: Addressing Unmet Needs in Cardiology, Neuroscience, and Respiratory Trials

Bethany Davis, M.D.

Trialmed

Neuro Biomarkers

Precision Neurology: How Biomarkers Are Redefining Clinical Trial Design

David Alvaro, Ph.D.